Stock Screener App

Frei -

Installieren

0.7748

0.67% -0.0052

after-market

Handel nachbörslich: .77 -0.0048 -0.62%

Estrella Immunopharma Inc (ESLA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$0.78

Offen:

$0.7666

24-Stunden-Volumen:

16,111

Relative Volume:

0.39

Marktkapitalisierung:

$33.34M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-13.25M

KGV:

-2.193

EPS:

-0.3533

Netto-Cashflow:

$-8.02M

1W Leistung:

-6.07%

1M Leistung:

-21.16%

6M Leistung:

-27.59%

1J Leistung:

-14.86%

1-Tages-Spanne:

$0.748

$0.7801

1-Wochen-Bereich:

$0.732

$0.83

52-Wochen-Spanne:

$0.73

$3.15

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Firmenname

Estrella Immunopharma Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (599)

Telefon

(510) 318-9098

Adresse

5858 HORTON STREET, SUITE 370, EMERYVILLE

Mitarbeiter

0

Twitter

Nächster Verdiensttermin

2026-05-13

Neueste SEC-Einreichungen

ESLA's Discussions on Twitter

Compare ESLA vs VRTX, REGN, ARGX, RVMD, ALNY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ESLA Estrella Immunopharma Inc	0.7748	33.57M	0	-13.25M	-8.02M	-0.3533
VRTX Vertex Pharmaceuticals Inc	479.00	121.16B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	667.17	68.78B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	888.82	57.44B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	188.07	40.23B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	278.40	36.28B	4.29B	577.22M	641.34M	4.2086

Estrella Immunopharma Inc Aktie (ESLA) Neueste Nachrichten

Estrella Immunopharma Inc (ESLA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Estrella Immunopharma Inc (ESLA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Estrella Immunopharma Inc (ESLA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Estrella Immunopharma Inc (ESLA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Estrella Immunopharma Inc (ESLA) Balance Sheet - TradingKey

TradingKey - TradingKey

Estrella Immunopharma Inc (ESLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

ESLA|Estrella Immunopharma Inc|Price:0.750|Chg%:-0.030 - TradingKey

Estrella Immunopharma Inc (ESLA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Estrella Immunopharma Inc (ESLA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

ESLA|Estrella Immunopharma Inc|Price:0.780| - TradingKey

Estrella Immunopharma Inc (ESLA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Estrella Immunopharma Inc (ESLA) Institutional Confidence - TradingKey

Estrella doses first patient in EB103 trial expansion phase - Investing.com

Estrella doses first patient in EB103 trial expansion phase By Investing.com - Investing.com Canada

Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma - Yahoo Finance

Price to sales forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Enterprise value to EBITDA forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Enterprise value to EBIT forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Estrella Immunopharma, Inc. (ESLA) stock price, news, quote and history - Yahoo Finance UK

Enterprise value to revenue forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Price to earnings forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Enterprise value to revenue forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Number of shareholders of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Price to sales forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Estrella Immunopharma Warrant (ESLAW) Holds Steady at $0.10 Amid Low VolatilityCalendar Spread Trade - dars.gov.et

Investigation launched into Estrella Immunophar... - Pluang

AGIG: Abbott Cooper PLLC Announces Investigation on Behalf of Abundia Global Impact Group, Inc. (Formerly Houston American Energy Corp.) Stockholders - GlobeNewswire Inc.

ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - GlobeNewswire

ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. ... - Caledonian Record

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

ESLA Q2 2026 Earnings: Wider-than-Expected Loss Triggers Stock DeclineEarnings Cycle Report - dars.gov.et

Tranche Update on Estrella Immunopharma, Inc.'s Equity Buyback Plan announced on January 30, 2024. - marketscreener.com

Estrella Immunopharma, Inc. (ESLA) 8-K Filing: Shareholder Vote Results & Company Details – June 2026 - Minichart

Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment - TipRanks

Estrella Immunopharma (ESLA) investors back 2026 auditor at virtual annual meeting - Stock Titan

Enterprise value to EBITDA forward of Estrella Immunopharma, Inc. – BOATS:ESLAW - TradingView

Price to earnings forward of Estrella Immunopharma, Inc. – BOATS:ESLAW - TradingView

Estrella Immunopharma Warrants (ESLAW) Edge Lower Amid Thin TradingRisk Parity Rebalance - dars.gov.et

Estrella Immunopharma, Inc.(NasdaqCM:ESLA) added to Russell Microcap Value Benchmark Index - marketscreener.com

Estrella Immunopharma, Inc.(NasdaqCM: ESLA) added to Russell 3000E Value Benchmark - marketscreener.com

Estrella Immunopharma Inc. (ESLA) Q1 2026 Earnings: Wider-than-Expected Loss Drives Stock Volatility - dars.gov.et

Estrella Immunopharma, Inc. Actuals & Estimates (NASDAQ:ESLA) - TradingView

ESLA Q1 2026 Earnings: EPS Misses Estimates by 90.6% Amid Pre-Revenue PhaseSlow Growth Warning - dars.gov.et

Estrella Immunopharma Inc. (ESLA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Estrella Immunopharma Inc (ESLAW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Estrella Immunopharma Inc (ESLAW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Estrella Immunopharma Inc - TradingKey

Estrella Immunopharma Inc (ESLAW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Estrella Immunopharma Inc (ESLAW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Estrella Immunopharma Inc (ESLAW) Institutional Confidence - TradingKey

Finanzdaten der Estrella Immunopharma Inc-Aktie (ESLA)

Umsatz

Nettogewinn

Free Cashflow

ENV

BNTX

$91.09

1.97%

INCY

$118.87

1.02%

ROIV

$34.72

0.83%

RPRX

$58.73

0.17%

ONC

$325.90

0.00%

ALNY

$278.40

2.44%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters